Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

TLSA Tiziana Life Sciences Ltd

0,775

-0,057 (-6,85%)

21 Dez 2024 - Geschlossen

Verzögert um 15 Minuten

This Biotech Found Significant Success Following Key Announcement

A New York-based biotech company is stealing the mid-week show after it announced the broadening of its Phase 2 clinical trial for non-active secondary progressive multiple...

To read the full story on AllPennyStocks.com, click here.

Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Tiziana Life Sciences Charts.

Tiziana Life Sciences (NASDAQ:TLSA)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Tiziana Life Sciences Charts.

News Tiziana Life Sciences Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 17 Dezember 2024 (4 Tage vor) • Edgar (US Regulatory)

Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
Dienstag 17 Dezember 2024 (4 Tage vor) • GlobeNewswire Inc.

This Biotech Found Significant Success Following Key Announcement
Mittwoch 4 Dezember 2024 (2 Wochen vor) • AllPennyStocks.com

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 4 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
Mittwoch 4 Dezember 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
Dienstag 19 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 1 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
Freitag 1 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 1 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
Donnerstag 31 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 30 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Tiziana Life Sciences Ltd News-Artikel

Euro vs US Dollar

BNP Paribas (QX)

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen